Rare disease advocates stage 'funeral' at FDA, demand 4 actions of agency and Congress
Rare disease advocates stage 'funeral' at FDA, demand 4 actions of agency and Congress
Rare disease advocates stage 'funeral' at FDA, demand 4 actions of agency and Congress
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.